| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| O Pucilowski, B Eichelma. Diltiazem suppresses quinpirole-induced oral stereotypies in haloperidol withdrawn rats. Progress in neuro-psychopharmacology & biological psychiatry. vol 15. issue 5. 1992-01-02. PMID:1683487. |
we conclude that concurrent diltiazem and haloperidol administration can prevent the occurrence of some behavioral manifestations of dopaminergic receptor supersensitivity, including a lingual dyskinesia. |
1992-01-02 |
2023-08-11 |
rat |
| Y Tian, K J Lookingland, K E Moor. Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons. Brain research. vol 555. issue 1. 1991-12-20. PMID:1681993. |
the da receptor antagonist haloperidol increased, while the da receptor agonist apomorphine decreased dopac concentrations in the mzi and dmn, indicating that alterations in the activity of incertohypothalamic dopaminergic neurons are accompanied by corresponding changes in the concentration of this da metabolite. |
1991-12-20 |
2023-08-11 |
rat |
| A Svensson, E Pileblad, M Carlsso. A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. Journal of neural transmission. General section. vol 85. issue 2. 1991-12-17. PMID:1930876. |
however, haloperidol pretreatment antagonized this locomotor response, indicating that the dopaminergic system plays a permissive role in this context. |
1991-12-17 |
2023-08-11 |
mouse |
| V Baudrie, F Chaoulof. Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucose. Neuropharmacology. vol 30. issue 6. 1991-10-31. PMID:1656302. |
conversely, the alpha 1-adrenoceptor antagonist, prazosin (1 mg/kg) or the dopaminergic receptor blocker, haloperidol (0.5 mg/kg) amplified the hyperglycaemic response to 2-dg. |
1991-10-31 |
2023-08-11 |
rat |
| G Improta, M Broccard. Sauvagine: inhibition of gastric acid secretion in rats. Peptides. vol 12. issue 3. 1991-10-31. PMID:1923934. |
blockade of adrenergic receptors by propranolol did not modify the antisecretory effect of sv, while the alpha-adrenergic antagonist, phentolamine, and the dopaminergic antagonist, haloperidol, potentiated the gastric response to the peptide. |
1991-10-31 |
2023-08-11 |
rat |
| N Kolocouris, G B Foscolos, G Fytas, A Sakellariou, C Raftopoulos, Z Papadopoulou-Daïfoti, A Vamvakidè. [Dopamine amides with essential or fundamental fatty acids. Synthesis and pharmacological study]. Annales pharmaceutiques francaises. vol 49. issue 2. 1991-10-28. PMID:1681774. |
the experimental results which are obtained from these derivatives (antagonized or non antagonized hypomotility by neuroleptics in low doses on mice, potentiation of the haloperidol catalepsy or not, on rats) could be compatible with a selective action of these amides on the autoreceptors of the cerebral dopaminergic neurons and with a preferential activity of some derivatives on certain cerebral areas (mesencephalon or striatum). |
1991-10-28 |
2023-08-11 |
mouse |
| F Rodriguez, T Joli. The role of somatostatin and/or dopamine in basal and TRH-stimulated TSH release in food-restricted rats. Acta endocrinologica. vol 125. issue 2. 1991-10-23. PMID:1680265. |
intravenous injections of the dopamine antagonists, domperidone or haloperidol, failed to affect the magnitude of the differences in plasma tsh and gh levels among control and food-restricted groups, indicating that dopaminergic mechanisms had little effect on the regulation of tsh and gh secretion during restricted feeding in rats. |
1991-10-23 |
2023-08-11 |
rat |
| G Pelletier, J Simar. Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus. Neuroscience letters. vol 127. issue 1. 1991-09-30. PMID:1679226. |
in order to study the role of dopamine on neuropeptide y (npy) gene expression in the rat arcuate nucleus, we evaluated the effects of haloperidol, a dopaminergic antagonist, and bromocriptine, a d2 dopamine receptor agonist, on the levels of pre-pronpy mrna as measured by in situ hybridization. |
1991-09-30 |
2023-08-11 |
rat |
| T Huo, D P Heal. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor. The Journal of pharmacology and experimental therapeutics. vol 258. issue 2. 1991-09-11. PMID:1830902. |
dopaminergic drugs were less potent competitors for [3h]domperidone binding in imcd cells than previously reported for brain da receptors, but the rank order was consistent with the labeling of a da receptor [antagonists: domperidone greater than spiperone greater than haloperidol greater than sch 23390 much greater than (-)-sulpiride; agonists: norapomorphine greater than fenoldopam much greater than dopamine = quinpirole], and was better correlated with the pharmacological profile for the brain d2 receptor than the brain d3 receptor. |
1991-09-11 |
2023-08-11 |
Not clear |
| A Kumar, R Raghubir, B N Dhawa. Effect of monoamine antagonists on pretectal evoked analgesia in rat. Indian journal of experimental biology. vol 29. issue 1. 1991-09-11. PMID:1864617. |
intracerebroventricular (icv) administration of 5-ht receptor antagonists methysergide (50 micrograms) and ketanserin (50 micrograms) and the dopaminergic antagonist haloperidol (50 micrograms) had no significant effect on pretectal spa, but alpha and beta adrenoceptor antagonists phenoxybenzamine (50 micrograms) and sotalol (50 micrograms) on icv injection significantly antagonised the pretectal spa. |
1991-09-11 |
2023-08-11 |
rat |
| T C Napier, P E Simson, B S Given. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. The Journal of pharmacology and experimental therapeutics. vol 258. issue 1. 1991-08-20. PMID:1677041. |
apo generally was antagonized by haloperidol, indicating that the agonist was acting at dopaminergic receptors to produce the observed rate changes. |
1991-08-20 |
2023-08-11 |
rat |
| S l'Héreault, N Barde. Regulation of proopiomelanocortin messenger RNA concentrations by opioid peptides in primary cell cultures of rat hypothalamus. Brain research. Molecular brain research. vol 10. issue 2. 1991-08-16. PMID:1649365. |
the failure of the dopaminergic d2 antagonist haloperidol to modify the inhibitory effects of opioid peptides argues for a direct inhibitory opioid peptide modulation of hypothalamic pomc mrna levels mediated by the delta-, kappa- and sigma- (but not mu-) receptors in vivo. |
1991-08-16 |
2023-08-11 |
rat |
| Y Umeda, C Watanabe, T Sum. A change in the spontaneous release of endogenous acetylcholine from rat striatal slices after repeated injection of haloperidol. Neuroscience letters. vol 123. issue 1. 1991-08-02. PMID:2062458. |
these results suggest that the spontaneous ach release is under the control of a dopaminergic mechanism, which might be different from the mechanism controlling the evoked release of ach and emerges following withdrawal from chronic haloperidol treatment. |
1991-08-02 |
2023-08-11 |
rat |
| E D Levin, J E Ros. Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance. Pharmacology, biochemistry, and behavior. vol 38. issue 2. 1991-07-31. PMID:1676165. |
the cognitive impairment caused by the muscarinic antagonist scopolamine is reversed by the dopaminergic (da) antagonist haloperidol as well as the selective d1 antagonist sch 23390. |
1991-07-31 |
2023-08-11 |
Not clear |
| Y Masuda, S Murai, H Saito, E Abe, H Fujiwara, I Kohori, T Ito. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice. Neuropharmacology. vol 30. issue 1. 1991-07-17. PMID:2046878. |
the enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice. |
1991-07-17 |
2023-08-11 |
mouse |
| Y Masuda, S Murai, H Saito, E Abe, H Fujiwara, I Kohori, T Ito. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice. Neuropharmacology. vol 30. issue 1. 1991-07-17. PMID:2046878. |
dopaminergic supersensitivity in mice was induced by pretreatment with a single injection of haloperidol (4.8 mg/kg). |
1991-07-17 |
2023-08-11 |
mouse |
| G A Higgins, C C Jordan, M Skingl. Evidence that the unilateral activation of 5-HT1D receptors in the substantia nigra of the guinea-pig elicits contralateral rotation. British journal of pharmacology. vol 102. issue 2. 1991-05-23. PMID:1849763. |
an involvement of dopaminergic systems in the rotational response to 5-ct was implied by the antagonism of 5-ct-induced rotation by haloperidol (0.3 mg kg-1, s.c.). |
1991-05-23 |
2023-08-11 |
Not clear |
| D Treit, K C Berridg. A comparison of benzodiazepine, serotonin, and dopamine agents in the taste-reactivity paradigm. Pharmacology, biochemistry, and behavior. vol 37. issue 3. 1991-05-23. PMID:1982355. |
in this experiment, the benzodiazepine agonist, diazepam, facilitated positive palatability reactions, while dopaminergic agents (haloperidol, apomorphine, amphetamine) had no significant effects on either positive or aversive reactions. |
1991-05-23 |
2023-08-11 |
rat |
| M J Fargeas, J Fioramonti, L Buen. Involvement of dopamine in the central effect of neurotensin on intestinal motility in rats. Peptides. vol 11. issue 6. 1991-05-23. PMID:2087439. |
the central effect of nt on the fed pattern involved dopaminergic neurons as it was mimicked by dopamine, blocked by haloperidol and partly antagonized by either sulpiride or (+) sch 23390. |
1991-05-23 |
2023-08-11 |
rat |
| C H Shue, C J Che. The excitatory effect of dopamine on isolated canine tracheal smooth muscle. The Journal of pharmacy and pharmacology. vol 42. issue 10. 1991-05-16. PMID:1982149. |
both a dopaminergic antagonist, haloperidol (10(-5) and 10(-4)m), and an alpha-adrenoceptor antagonist, phentolamine (10(-7) to 10(-5)m), attenuated the contraction to 10(-3)m dopamine. |
1991-05-16 |
2023-08-11 |
Not clear |